Background. The morbidity of treating benign parotid tumors is an impo
rtant issue because the majority of patients are young. We therefore u
ndertook this study to evaluate the outcome for these patients treated
at the Princess Margaret Hospital. Methods. A retrospective review wa
s conducted on all patients registered with benign parotid tumors betw
een 1970 and 1987. Results. Seventy-six patients were included in this
review; postoperative radiotherapy (XRT) was administered to 55 patie
nts. Median follow-up time was 12.5 years. Postoperative XRT was parti
cularly important for patients with recurrent disease. The risk of bot
h temporary and permanent facial nerve paralyses increased with each o
peration. No patients in this study developed a malignancy.Conclusions
. We recommend that all patients with benign parotid tumors be treated
with a complete parotidectomy with preservation of the facial nerve.
Consideration to postoperative XRT should be given to patients in whom
there was tumor spillage, residual disease, or recurrences. (C) 1995
John Wiley and Sons, Inc.